Pierre Loap

1.3k total citations
95 papers, 788 citations indexed

About

Pierre Loap is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pierre Loap has authored 95 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 41 papers in Cancer Research and 36 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pierre Loap's work include Breast Cancer Treatment Studies (39 papers), Advanced Radiotherapy Techniques (31 papers) and Radiation Therapy and Dosimetry (14 papers). Pierre Loap is often cited by papers focused on Breast Cancer Treatment Studies (39 papers), Advanced Radiotherapy Techniques (31 papers) and Radiation Therapy and Dosimetry (14 papers). Pierre Loap collaborates with scholars based in France, Italy and United States. Pierre Loap's co-authors include Youlia Kirova, Alain Fourquet, K. Kirov, Ludovic De Marzi, Delphine Loirat, Youlia Kirova, Amelia Barcellini, Ester Orlandi, R. Dendale and F. Goudjil and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Radiology.

In The Last Decade

Pierre Loap

75 papers receiving 781 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Loap France 18 332 294 293 242 230 95 788
Anne P.G. Crijns Netherlands 16 279 0.8× 273 0.9× 286 1.0× 449 1.9× 353 1.5× 33 1.1k
Michael S. Binkley United States 12 378 1.1× 202 0.7× 187 0.6× 159 0.7× 210 0.9× 45 688
Trine Jakobi Nøttrup Denmark 8 236 0.7× 188 0.6× 353 1.2× 226 0.9× 248 1.1× 18 674
Nadia Pasinetti Italy 13 368 1.1× 270 0.9× 76 0.3× 160 0.7× 160 0.7× 38 809
Christoph Henkenberens Germany 19 776 2.3× 183 0.6× 83 0.3× 562 2.3× 146 0.6× 50 1.0k
George M. Cannon United States 15 564 1.7× 204 0.7× 358 1.2× 224 0.9× 232 1.0× 42 858
Imogen Locke United Kingdom 16 301 0.9× 208 0.7× 298 1.0× 246 1.0× 288 1.3× 39 798
K. Pigott United Kingdom 14 509 1.5× 337 1.1× 127 0.4× 455 1.9× 184 0.8× 24 863
Zsolt Gabos Canada 16 499 1.5× 462 1.6× 264 0.9× 339 1.4× 211 0.9× 40 1.2k
Stefano Vagge Italy 13 180 0.5× 114 0.4× 166 0.6× 161 0.7× 64 0.3× 39 472

Countries citing papers authored by Pierre Loap

Since Specialization
Citations

This map shows the geographic impact of Pierre Loap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Loap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Loap more than expected).

Fields of papers citing papers by Pierre Loap

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Loap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Loap. The network helps show where Pierre Loap may publish in the future.

Co-authorship network of co-authors of Pierre Loap

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Loap. A scholar is included among the top collaborators of Pierre Loap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Loap. Pierre Loap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Loap, Pierre, et al.. (2025). Safety and Tolerability of Concurrent Radiotherapy and Sacituzumab Govitecan in Metastatic Breast Cancer. American Journal of Clinical Oncology. 48(8). 399–402. 3 indexed citations
2.
Loap, Pierre, et al.. (2025). Exposure to the immune system during bridging radiotherapy for Car-T cells. Cancer/Radiothérapie. 29(2). 104595–104595.
3.
Ramtohul, Toulsie, Lounes Djerroudi, Thomas Gaillard, et al.. (2025). Posttreatment MRI to Predict Pathologic Complete Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy. Radiology. 316(1). e243824–e243824.
4.
Schneider, Tim, et al.. (2025). Photon mini‐GRID therapy for preoperative breast cancer tumor treatment: A treatment plan study. Medical Physics. 52(4). 2493–2506. 3 indexed citations
5.
6.
Loap, Pierre, Youlia Kirova, & R. Dendale. (2024). Primary ophthalmic natural killer/T-cell lymphoma: A population-based study. Bulletin du Cancer. 111(3). 310–313.
7.
Hannoun‐Lévi, Jean‐Michel, Alexia Savignoni, Caroline Malhaire, et al.. (2024). Management of second ipsilateral breast tumor event: An advocacy for a randomized trial. Cancer/Radiothérapie. 28(2). 188–194. 3 indexed citations
8.
Loap, Pierre, et al.. (2024). Concurrent Use of Radiotherapy and Ribociclib. American Journal of Clinical Oncology. 47(12). 574–579. 2 indexed citations
9.
Kirova, Youlia, Pierre Loap, Kim Cao, et al.. (2024). Abstract PO1-03-05: Tolerance of adjuvant radiotherapy combined with pembrolizumab for triple negative breast cancer. Cancer Research. 84(9_Supplement). PO1–3.
10.
Loap, Pierre, et al.. (2024). Concurrent Use of Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer. American Journal of Clinical Oncology. 47(12). 580–584. 7 indexed citations
11.
12.
Loap, Pierre, Kim Cao, Manon Kissel, et al.. (2023). Tolerance of Concurrent Adjuvant Radiation Therapy and Pembrolizumab for Triple Negative Breast Cancer: Real Life Experience. Advances in Radiation Oncology. 9(3). 101384–101384. 11 indexed citations
13.
Loap, Pierre, et al.. (2022). Do We Need to Delineate the Humeral Head in Breast Cancer Patients?. Cancers. 14(3). 496–496. 2 indexed citations
14.
Fontana, Giulia, Amelia Barcellini, Pierre Loap, et al.. (2022). Role of diffusion-weighted MRI in recurrent rectal cancer treated with carbon ion radiotherapy. Future Oncology. 18(22). 2403–2412. 1 indexed citations
15.
Locquet, Médéa, David Broggio, G. Jimenez, et al.. (2022). Supraventricular cardiac conduction system exposure in breast cancer patients treated with radiotherapy and association with heart and cardiac chambers doses. Clinical and Translational Radiation Oncology. 38. 62–70. 9 indexed citations
16.
Loap, Pierre, Ludovic De Marzi, Carlos Eduardo Almeida, et al.. (2021). Hadrontherapy techniques for breast cancer. Critical Reviews in Oncology/Hematology. 169. 103574–103574. 12 indexed citations
17.
Loap, Pierre, Ludovic De Marzi, Alfredo Mirandola, et al.. (2021). Development and Implementation of Proton Therapy for Hodgkin Lymphoma: Challenges and Perspectives. Cancers. 13(15). 3744–3744. 12 indexed citations
18.
Loap, Pierre, Alfredo Mirandola, Ludovic De Marzi, et al.. (2021). Current Situation of Proton Therapy for Hodgkin Lymphoma: From Expectations to Evidence. Cancers. 13(15). 3746–3746. 14 indexed citations
19.
Barcellini, Amelia, Pierre Loap, Kazutoshi Murata, et al.. (2021). PARP Inhibitors in Combination with Radiotherapy: To Do or Not to Do?. Cancers. 13(21). 5380–5380. 32 indexed citations
20.
Loap, Pierre & Youlia Kirova. (2020). Fast Neutron Therapy for Breast Cancer Treatment: An Effective Technique Sinking into Oblivion. International Journal of Particle Therapy. 7(3). 61–64. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne P.G. Crijns Breakdown of academic impact, for papers by Michael S. Binkley Breakdown of academic impact, for papers by Trine Jakobi Nøttrup Breakdown of academic impact, for papers by Nadia Pasinetti Breakdown of academic impact, for papers by Christoph Henkenberens Breakdown of academic impact, for papers by George M. Cannon Breakdown of academic impact, for papers by Imogen Locke Breakdown of academic impact, for papers by K. Pigott Breakdown of academic impact, for papers by Zsolt Gabos Breakdown of academic impact, for papers by Stefano Vagge
Rankless by CCL
2026